# Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease

Study · id `cardio:ct-nct06737757` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06737757](<https://clinicaltrials.gov/study/NCT06737757>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06737757

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 198 participants.

## Technical summary

Registry record NCT06737757. Randomized; single masking; primary purpose treatment. Start 2024-12 (anticipated); primary completion 2026-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 198 participants (planned count; ClinicalTrials.gov record NCT06737757, source copy `cardio:ctgov-nct06737757-2024-12-30`, retrieved 2026-10-26)
- Planned start: 2024-12 (anticipated) (ClinicalTrials.gov record NCT06737757, source copy `cardio:ctgov-nct06737757-2024-12-30`, retrieved 2026-10-26)
- Primary completion: 2026-08 (anticipated) (ClinicalTrials.gov record NCT06737757, source copy `cardio:ctgov-nct06737757-2024-12-30`, retrieved 2026-10-26)
- Completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT06737757, source copy `cardio:ctgov-nct06737757-2024-12-30`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06737757-2024-12-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease
- Condition: Aortic Valve Stenosis
- Condition: Aortic Valve Disease
- Condition: Aortic Valve Regurgitation
- Intervention (Device): Artificial polymer heart valves
- Intervention (Device): Bovine pericardial aortic valve
- Lead sponsor: Suzhou Hearthill Medical Technology Co.,LTD
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic regurgitation (`cardio:aortic-regurgitation`)
- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 1f024e05608fe94fd449cc4fe35b55a2f3ab34dff32d11f3fd5dea86de28e9e2
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
